Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032

By HospiMedica International staff writers
Posted on 25 Jan 2023

The global point-of-care (POC) glucose testing market is projected to register a CAGR of 4. More...

3% during the forecast period from 2022 to 2032 to reach USD 5.8 billion by 2032, driven by a rise in the geriatric population, speed & precision of POC screening, increased adoption of electronic medical information, and the higher risk of COVID-19-related mortality associated with diabetes. These are the latest findings of Transparency Market Research, (Wilmington, DE, USA), a global market research company.

Technological advancements, such as needle-free blood glucose monitoring devices that offer painless treatment for diabetes, are propelling the growth of the POC glucose testing market. The increased adoption of POC glucose testing gadgets across healthcare centers has created huge growth opportunities for the POC glucose testing industry. These gadgets provide instant test reports and are therefore being adopted in surgical operating rooms, emergency rooms, critical care units, diagnostic laboratories, and hospitals, driving the global glucose testing market. POC diagnostics is gaining popularity due to its advantages such as quick, simple, portable diagnosis and self-monitoring. These devices provide diagnostic and monitoring capabilities to patients in clinics, hospitals, as well as at home, thereby acting as a key growth driver of the POC glucose testing market.

Geographically, North America was the world’s largest market for POC glucose testing in 2021, accounting for around 40% of total sales. Currently, the region is home to leading players, which combined with the easy availability of diabetes testing kits though a smooth distribution process will help North America maintain its dominant position. Additionally, governments in the region have increased expenditure on healthcare, especially for diabetes, which is one of the factors driving the POC glucose testing market in North America. The POC glucose testing market in Asia Pacific is expected to be driven by a rise in the prevalence of diabetes, expanding healthcare infrastructure and growing demand for testing due to increased patient reluctance to take hospital appointments.

Related Links:
Transparency Market Research 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.